The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
Abstract
Most lymphomas that involve the central nervous system are B-cell neoplasms that express the cell surface molecule CD20. After intravenous administration, rituximab can be reproducibly measured in the cerebrospinal fluid (CSF) in patients with primary central nervous system lymphoma; however, the CSF levels of rituximab are approximately 0.1% of serum levels associated with therapeutic activity in patients with systemic non-Hodgkin lymphoma. Because lymphomatous meningitis is a frequent complication of non-Hodgkin lymphoma, we have conducted an analysis of the safety and pharmacokinetics of direct intrathecal administration of rituximab using cynomolgus monkeys. No significant acute or delayed toxicity, neurologic or otherwise, was detected. Pharmacokinetic analysis suggests that drug clearance from the CSF is biphasic, with a terminal half-life of 4.96 hours. A phase 1 study to investigate the safety and pharmacokinetics of intrathecal rituximab in patients with recurrent lymphomatous meningitis will be implemented based on these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simplex Method for Function Minimization
Nelder, J. A., & Mead, R. (1965) · The Computer Journal · doi:10.1093/comjnl/7.4.308 · Cited by 28,905
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Maloney, D., Liles, T., Czerwinski, D., Waldichuk, C., Rosenberg, J., Grillo-Lopez, A., & Levy, R. (1994) · Blood · doi:10.1182/blood.v84.8.2457.2457 · Cited by 762
Self-citationMaloney, D. G., Grillo-López, A. J., Bodkin, D. J., White, C. A., Liles, T. M., Royston, I., Varns, C., Rosenberg, J., & Levy, R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3266 · Cited by 636
Self-citationGlantz, M. J., LaFollette, S., Jaeckle, K. A., Shapiro, W., Swinnen, L., Rozental, J. R., Phuphanich, S., Rogers, L. R., Gutheil, J. C., Batchelor, T., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3110 · Cited by 402
van Besien, K., Ha, C. S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaguera, J., Hagemeister, F., Younes, A., et al. (1998) · Blood · doi:10.1182/blood.v91.4.1178 · Cited by 275
Bleyer, W. A., & Poplack, D. G. (1979) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950060304 · Cited by 110
A primate model for study of methotrexate pharmacokinetics in the central nervous system.
Poplack, D. G., Bleyer, W. A., Wood, J. H., Kostolich, M., Savitch, J. L., & Ommaya, A. K. (1977) · PubMed · Cited by 45
Cited by
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604318103 · Cited by 645
B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke
Doyle, K. P., Quach, L. N., Solé, M., Axtell, R. C., Nguyen, T.-V. V., Soler-Llavina, G. J., Jurado, S., Han, J., Steinman, L., Longo, F. M., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4098-14.2015 · Cited by 339
Targeted delivery of antibodies through the blood–brain barrier by MRI-guided focused ultrasound
Kinoshita, M., McDannold, N., Jolesz, F. A., & Hynynen, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.112 · Cited by 337
Rubenstein, J. L., Fridlyand, J., Abrey, L., Shen, A., Karch, J., Wang, E., Issa, S., Damon, L., Prados, M., McDermott, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7311 · Cited by 327
Self-citationMeinl, E., Krumbholz, M., & Hohlfeld, R. (2006) · Annals of Neurology · doi:10.1002/ana.20890 · Cited by 310
Metadata
- Authors
- Rubenstein, J. L., Combs, D., Rosenberg, J., Levy, A., McDermott, M., Damon, L., Ignoffo, R., Aldape, K., Shen, A., Lee, D., Grillo-Lopez, A., & Shuman, M. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2003-01-15
- Volume
- 101
- Issue
- 2
- Pages
- 466-468
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2126778627
- Cited by
- 423
- References
- 9
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. https://app.cochat.ai/papers/10.1182/blood-2002-06-1636
- The paper
- Rubenstein, J. L., Combs, D., Rosenberg, J., Levy, A., McDermott, M., Damon, L., Ignoffo, R., Aldape, K., Shen, A., Lee, D., Grillo-Lopez, A., & Shuman, M. A. (2003). Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. https://doi.org/10.1182/blood-2002-06-1636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.